US Stock MarketDetailed Quotes

NRXPW NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM)

Watchlist
  • 0.1700
  • -0.0200-10.53%
Close Apr 18 16:00 ET
0Market Cap0.00P/E (TTM)

About NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) Company

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Company Profile

SymbolNRXPW
Company NameNRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM)
Listing DateDec 1, 2017
Founded2017
CEOMr. Stephen H. Willard
MarketNASDAQ
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1201 Orange Street,Suite 600
CityWilmington
ProvinceDelaware
CountryUnited States of America
Zip Code19801
Phone1-484-254-6134
Websitehttp://www.nrxpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Stephen H. Willard
  • Director, Chief Executive Officer and Acting Corporate Secretary
  • 799.87K
  • Richard Clavano Narido
  • Interim Chief Financial Officer and Principal Accounting Officer
  • --
  • Patrick J. Flynn
  • Chairman of our Board
  • 180.00K
  • Dr. Jonathan C. Javitt,M.D.,M.P.H.
  • Director and Chief Scientist
  • 873.70K
  • Chaim Hurvitz
  • Independent Director
  • 160.00K
  • Aaron Gorovitz
  • Independent Director
  • 170.00K
  • Dr. Sharon A. Glied, PhD
  • Independent Director
  • 160.00K
  • Riccardo Panicucci
  • CMC and Technical Operations Advisor
  • 240.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg